Input costs leave Godrej Agrovet's margin well below FMCG peers
Dairy, foods and crop-care pressures offset growth in Animal Nutrition, while management outlined continued capex and new-product expansion.
Filed 05 Aug 2026, 15:31 IST · after market close · Godrej Agrovet Ltd (GODREJAGRO)
Key takeaways
- Godrej Agrovet's consolidated operating margin was 8.41%, 7.57 percentage points below the 15.98% median of 28 reported FMCG peers.
- Input-cost pressure at Creamline Dairy and Godrej Foods, along with muted crop-care demand, weighed on the quarter while Animal Nutrition volumes grew 7.2% year on year.
- Management said annual capex would continue at Rs 300–350 crore, funded through internal accruals.
Price around the results
8.41% operating margin trails the sector
Godrej Agrovet reported consolidated operating profit of Rs 240.18 cr on revenue of Rs 2,855.22 cr in Q1FY27. Its 8.41% operating margin was 7.57 percentage points below the 15.98% median for 28 FMCG peers that had reported, placing it sixth from the bottom. The results were filed after market close on 5 Aug 2026.
Milk, food inputs and crop-care demand pressured profitability
Management said Creamline Dairy's profitability was affected by elevated milk procurement prices, constrained milk availability and inflation in other inputs. It also said Godrej Foods could only partly offset higher input costs through calibrated pricing actions. Crop-care demand was muted by delayed monsoon progress and slower kharif sowing after a very dry June, with revenue mainly affected by lower in-house cotton herbicide volumes.
Animal Nutrition growth partly offset crop-care weakness
Management said Animal Nutrition volume grew 7.2% year on year, supported by demand-led expansion and improved realizations, while cattle-feed volumes rose approximately 15%. Oil Palm revenue benefited from better realizations and higher sales volumes, although fresh fruit bunch volumes remained broadly flat. The company said Ashitaka maize herbicide volumes reached 30 kL after scaling approximately threefold in Q1FY27, and Ghassnash recorded 26 kL of sales after its May 2026 launch.
Management is expanding capacity and the product pipeline
Management said it plans to maintain annual capex of Rs 300–350 crore through internal accruals. It said Ghassnash is planned to ramp up further in Q2 and that the automated momo line commissioned in July 2026 is expected to add scale. The company also said a new commercialization team would launch patented crop-care solutions, including Takai claims approved for five additional crops and a soybean herbicide.
Q1FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q1FY27 |
|---|---|
| Revenue | ₹2,855 cr |
| Other income | ₹27 cr |
| Expenses | ₹2,615 cr |
| Operating profit | ₹240 cr |
| Operating margin (%) | 8.41% |
| Interest | ₹30 cr |
| Depreciation | ₹57 cr |
| Profit before tax | ₹181 cr |
| Tax | ₹53 cr |
| Net profit | ₹128 cr |
| EPS (₹) | ₹6.99 |
Operating margin of 8.41% compares with a Fast Moving Consumer Goods sector median of 15.98% across 28 peers that have reported Q1FY27.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
This quarter
- Animal Nutrition volume increased 7.2% year on year, supported by strong demand-led expansion and improved realizations.
- Cattle-feed volumes grew approximately 15% year on year.
- Oil Palm revenue was driven by improved realizations and higher sales volumes, while FFB volumes were broadly flat.
Guidance & outlook
- The company plans to continue capex of ₹300–350 crore per year, funded through internal accruals.
- Ghassnash is planned to ramp up further in Q2 after its May 2026 launch.
- Further scale is expected from the new automated momo line commissioned in July 2026.
Expansion
- The company has set up a new commercialization team to launch patented crop-care solutions.
- The new automated momo line was commissioned in July 2026.
New products
- Ashitaka maize herbicide volumes reached 30 kL in Q1 FY27 after scaling approximately threefold.
- Ghassnash, a soybean herbicide, launched in May 2026 and recorded 26 KL of Q1 sales.
New initiatives
- The company is diversifying crop-care products beyond paddy, with Takai label claims approved for five additional crops.
- The company is entering soybeans with a new herbicide product.
- Godrej Foods is pursuing branded growth through new product development across three core categories.
Competition
- Godrej Foods’ quick-commerce market share for frozen chicken increased significantly versus Q1 FY26.
- Godrej Foods’ quick-commerce market share for nuggets nearly doubled to 9% from 5% in Q4 FY26.
Problems & risks
- Crop-care demand was muted because of delayed monsoon progress and slower kharif sowing after a very dry June.
- Crop-care revenue declined mainly because of lower in-house cotton herbicide volumes.
- Creamline Dairy EBITDA was affected by elevated milk procurement prices, constrained milk availability and inflation in other inputs.
- Godrej Foods EBITDA margins moderated because of higher input costs and geopolitical inflationary pressure.
- Godrej Foods could only partially offset higher costs despite calibrated pricing actions.
What to watch
- Whether consolidated operating margin holds above 8.41%.
- Whether Ghassnash sales move beyond the 26 kL recorded in Q1FY27 as management's planned Q2 ramp-up progresses.
- Whether annual capex remains within the Rs 300–350 crore range stated by management.